TY - JOUR
T1 - Proanthocyanidins-loaded complex coacervates-based drug delivery attenuates oral squamous cell carcinoma cells metastatic potential through down-regulating the Akt signaling pathway
AU - Liu, Ju Fang
AU - Wee, Yinshen
AU - Luo, Shen Dean
AU - Chang, Shwu Fen
AU - Jia, Shihai
AU - Feng, Sheng Wei
AU - Huang, Huei Mei
AU - Lin, Jiann Her
AU - Wang, Ching Shuen
N1 - Funding Information:
This research was funded by the Ministry of Science and Technology (MOST), Taiwan, grant number 110-2320-B-038-015 and TMU Research Center of Cancer Translational Medicine from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan, Grant/Award Numbers: DP2-111-21121-01-O-10-03.
Publisher Copyright:
Copyright © 2022 Liu, Wee, Luo, Chang, Jia, Feng, Huang, Lin and Wang.
PY - 2022/10/18
Y1 - 2022/10/18
N2 - Oral cancer, constituted up to 90% by squamous cell carcinomas, is a significant health burden globally. Grape seed proanthocyanidins (PA) have been suggested as a potential chemopreventive agent for oral cancer. However, their efficacy can be restricted due to the low bioavailability and bioaccessibility. Inspired by sandcastle worm adhesive, we adapted the concept of complex coacervation to generate a new type of drug delivery platform. Complex coacervates are a dense liquid phase formed by the associative separation of a mixture of oppositely charged polyelectrolytes, can serve as a drug delivery platform to protect labile cargo. In this study, we developed a complex coacervates-based delivery of PA. The release kinetics was measured, and anticancer effects were determined in two human tongue squamous cell carcinoma cell lines. The results showed that complex coacervate successfully formed and able to encapsulate PA. Additionally, PA were steadily released from the system in a pH-dependent manner. The drug delivery system could significantly inhibit the cell proliferation, migration, and invasion of cancer cells. Moreover, it could markedly reduce the expression of certain matrix metalloproteinases (MMP-2, 9, and 13) crucial to metastatic processes. We also found that suppression of protein kinase B (Akt) pathway might be the underlying mechanism for these anticancer activities. Taken together, complex coacervates-based delivery of PA can act as an effective anticancer approach for oral cancer therapy.
AB - Oral cancer, constituted up to 90% by squamous cell carcinomas, is a significant health burden globally. Grape seed proanthocyanidins (PA) have been suggested as a potential chemopreventive agent for oral cancer. However, their efficacy can be restricted due to the low bioavailability and bioaccessibility. Inspired by sandcastle worm adhesive, we adapted the concept of complex coacervation to generate a new type of drug delivery platform. Complex coacervates are a dense liquid phase formed by the associative separation of a mixture of oppositely charged polyelectrolytes, can serve as a drug delivery platform to protect labile cargo. In this study, we developed a complex coacervates-based delivery of PA. The release kinetics was measured, and anticancer effects were determined in two human tongue squamous cell carcinoma cell lines. The results showed that complex coacervate successfully formed and able to encapsulate PA. Additionally, PA were steadily released from the system in a pH-dependent manner. The drug delivery system could significantly inhibit the cell proliferation, migration, and invasion of cancer cells. Moreover, it could markedly reduce the expression of certain matrix metalloproteinases (MMP-2, 9, and 13) crucial to metastatic processes. We also found that suppression of protein kinase B (Akt) pathway might be the underlying mechanism for these anticancer activities. Taken together, complex coacervates-based delivery of PA can act as an effective anticancer approach for oral cancer therapy.
KW - chemopreventive agent
KW - complex coacervates
KW - grape seed proanthocyanidins
KW - matrix metalloproteinases
KW - novel drug carrier
KW - oral squamous cell carcinoma
KW - protein kinase B
UR - http://www.scopus.com/inward/record.url?scp=85141169911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141169911&partnerID=8YFLogxK
U2 - 10.3389/fonc.2022.1001126
DO - 10.3389/fonc.2022.1001126
M3 - Article
AN - SCOPUS:85141169911
SN - 2234-943X
VL - 12
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 1001126
ER -